Literature DB >> 17537571

Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization.

Thilo Welsch1, Karlhans Endlich, Thomas Giese, Markus W Büchler, Jan Schmidt.   

Abstract

We investigated the role of Eps8 in pancreatic cancer. Eps8 was significantly increased in pancreatic cancer and colocalized with F-actin, predominantly in pancreatic ductal cells. Eps8 levels were higher in cell lines derived from ascites and metastases than in those from primary tumors. Expression correlated positively with the migratory potential of tumor cells. Eps8 localized to the tips of F-actin filaments, filopodia, and the leading edge of cells. Eps8 knockdown altered cell shape and actin-based cytoskeletal structures, impairing protrusion formation and cell-cell junctions. We concluded that Eps8 is increased in pancreatic cancer and correlates with migratory potential and tumor progression in vitro. Eps8 is essential for actin dynamics and cell interactions, independent of Eps8-like gene products.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537571     DOI: 10.1016/j.canlet.2007.04.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  33 in total

1.  Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

Authors:  Richard Marcotte; Kevin R Brown; Fernando Suarez; Azin Sayad; Konstantina Karamboulas; Paul M Krzyzanowski; Fabrice Sircoulomb; Mauricio Medrano; Yaroslav Fedyshyn; Judice L Y Koh; Dewald van Dyk; Bodhana Fedyshyn; Marianna Luhova; Glauber C Brito; Franco J Vizeacoumar; Frederick S Vizeacoumar; Alessandro Datti; Dahlia Kasimer; Alla Buzina; Patricia Mero; Christine Misquitta; Josee Normand; Maliha Haider; Troy Ketela; Jeffrey L Wrana; Robert Rottapel; Benjamin G Neel; Jason Moffat
Journal:  Cancer Discov       Date:  2011-12-29       Impact factor: 39.397

2.  Differential roles of EPS8 in carcinogenesis: loss of protein expression in a subset of colorectal carcinoma and adenoma.

Authors:  Wael M Abdel-Rahman; Salla Ruosaari; Sakari Knuutila; Päivi Peltomäki
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

3.  c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8).

Authors:  Shreya Mitra; Ju-Seog Lee; Michael Cantrell; Carla Lynn Van den Berg
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

4.  Eps8 is recruited to lysosomes and subjected to chaperone-mediated autophagy in cancer cells.

Authors:  Thilo Welsch; Alexander Younsi; Andrea Disanza; Jose Antonio Rodriguez; Ana Maria Cuervo; Giorgio Scita; Jan Schmidt
Journal:  Exp Cell Res       Date:  2010-02-23       Impact factor: 3.905

5.  Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.

Authors:  Huijun Chen; Xufeng Wu; Zhixing K Pan; Shuang Huang
Journal:  Cancer Res       Date:  2010-11-30       Impact factor: 12.701

Review 6.  Palladin regulation of the actin structures needed for cancer invasion.

Authors:  Paul Najm; Mirvat El-Sibai
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

7.  Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.

Authors:  Gina L Razidlo; Yu Wang; Jing Chen; Eugene W Krueger; Daniel D Billadeau; Mark A McNiven
Journal:  Dev Cell       Date:  2013-03-25       Impact factor: 12.270

Review 8.  The role of palladin in actin organization and cell motility.

Authors:  Silvia M Goicoechea; Daniel Arneman; Carol A Otey
Journal:  Eur J Cell Biol       Date:  2008-03-14       Impact factor: 4.492

9.  Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.

Authors:  Stella Koutros; Sonja I Berndt; Rashmi Sinha; Xiaomei Ma; Nilanjan Chatterjee; Michael C R Alavanja; Tongzhang Zheng; Wen-Yi Huang; Richard B Hayes; Amanda J Cross
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

10.  Palladin contributes to invasive motility in human breast cancer cells.

Authors:  S M Goicoechea; B Bednarski; R García-Mata; H Prentice-Dunn; H J Kim; C A Otey
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.